1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Benign Neoplasms in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abo, H; Akita, H; Arai, T; Hatakeyama, H; Hirakawa, J; Hisaka, A; Kawashima, H; Kokubo, T; Tang, R; Terui, A | 1 |
| Rohan, JG; Sahu, RP; Travers, JB | 1 |
| Lordan, R; Tsoupras, A; Zabetakis, I | 1 |
| Danker, K; Hildmann, A; Semini, G; von Haefen, C | 1 |
| Dynarowicz-Łątka, P; Flasiński, M; Hąc-Wydro, K; Wydro, P | 1 |
| Demopoulos, CA; Frangia, C; Iatrou, C; Tsoupras, AB | 1 |
| Danker, K; Reutter, W; Semini, G | 1 |
| Danker, K; Klein, A; Semini, G | 1 |
| Podolak-Dawidziak, M | 1 |
| Taylor, KE | 1 |
| Kurnatowska, A; Lewkowicz, N; Lewkowicz, P; Tchórzewski, H | 1 |
| Andrade, SP; Bakhle, YS; Barcelos, LS; Ferreira, MA; Teixeira, MM | 1 |
| Bravo, S; Bussolati, B; Camussi, G; Ceretto, M; Doublier, S; Lupia, E | 1 |
| Aglietta, M; Bretti, S; Fubini, L; Morelli, S; Pasquino, P; Sanavio, F; Severino, A; Stacchini, A; Tafuto, S; Volta, C | 1 |
| Aosasa, S; Kinoshita, M; Mochizuki, H; Oda, Y; Ohe, H; Ohkusa, Y; Ono, S; Tamakuma, S | 1 |
| Albini, A; Bussolino, F; Camussi, G; Persico, G; Presta, M; Viglietto, G; Ziche, M | 1 |
| Berthou, C; Bourge, JF; Denizot, Y; Geromin, D; Sasportes, M; Sigaux, F; Soulié, A; Zhang, Y | 1 |
| Bolvacheva, AV; Bykovskaya, SN; Bykovsky, AF; Khaylenko, VA; Kiselevsky, MV | 1 |
| Aglietta, M; Aprà, F; Bussolino, F; Giribaldi, G; Monzeglio, C; Mossetti, C; Stern, AC | 1 |
| Benveniste, J; Burtin, C; Noirot, C; Paupe, J; Scheinmann, P | 1 |
| Barbieri, D; Meloni Bruneri, LH | 1 |
8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Benign Neoplasms
| Article | Year |
|---|---|
New Insights Into the Pathologic Roles of the Platelet-Activating Factor System.
Topics: Animals; Cell-Derived Microparticles; Humans; Neoplasms; Oxidative Stress; Platelet Activating Factor; Skin | 2021 |
The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.
Topics: Diet; Diet, Mediterranean; Disease Progression; Humans; Neoplasms; Platelet Activating Factor | 2019 |
Glycosidated phospholipids - a promising group of anti-tumour lipids.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Differentiation; Cell Movement; Cell Proliferation; Extracellular Matrix; Gene Expression; Glycosylation; Humans; Inositol; Neoplasms; Phospholipids; Platelet Activating Factor | 2014 |
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants.
Topics: Animals; Antioxidants; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2009 |
Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.
Topics: Animals; Antineoplastic Agents; Cell Membrane; Cell Movement; Cell Proliferation; Glycosides; Humans; Inositol; Molecular Structure; Neoplasm Metastasis; Neoplasms; Phospholipids; Platelet Activating Factor; Signal Transduction | 2010 |
[Role of white cells and neoplastic cells in haemostasis].
Topics: Cell Transformation, Neoplastic; Hemostasis; Humans; Leukocytes; Neoplasms; Platelet Activating Factor; Transforming Growth Factors | 2002 |
[Biological action and clinical application of shark liver oil].
Topics: Animals; Antineoplastic Agents; Apoptosis; Diglycerides; Fish Oils; Humans; Inflammation; Neoplasms; Neovascularization, Pathologic; Platelet Activating Factor; Sharks; Signal Transduction; Squalene | 2006 |
Role of soluble mediators in angiogenesis.
Topics: Amino Acid Sequence; Animals; Autacoids; Chick Embryo; Endothelial Growth Factors; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Gene Products, tat; Growth Substances; Hepatocyte Growth Factor; Humans; Lymphokines; Mice; Molecular Sequence Data; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide; Placenta Growth Factor; Platelet Activating Factor; Pregnancy; Pregnancy Proteins; Rabbits; Rats; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |
14 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Benign Neoplasms
| Article | Year |
|---|---|
Tumor-associated neutrophils and macrophages exacerbate antidrug IgG-mediated anaphylactic reaction against an immune checkpoint inhibitor.
Topics: Anaphylaxis; Animals; Chromatography, Liquid; Humans; Immune Checkpoint Inhibitors; Immunoglobulin G; Macrophages; Mice; Neoplasms; Neutrophils; Platelet Activating Factor; Tandem Mass Spectrometry | 2022 |
Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level.
Topics: Antineoplastic Agents; Cell Membrane; HL-60 Cells; Humans; K562 Cells; Membranes, Artificial; Neoplasms; Phospholipid Ethers; Plasmalogens; Platelet Activating Factor | 2014 |
Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line; Cell Membrane; Cell Movement; Cell Proliferation; Gene Expression Profiling; Humans; Immunity, Innate; Keratinocytes; Neoplasms; Oligonucleotide Array Sequence Analysis; Phospholipid Ethers; Platelet Activating Factor; Transcription, Genetic | 2011 |
Familial cancer and developmental dyslexia: an observational pilot study.
Topics: Adolescent; Case-Control Studies; Child; Dyslexia; Female; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Pedigree; Platelet Activating Factor | 2004 |
Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
Topics: Acetylglucosaminidase; Animals; Ascites; Carcinoma, Ehrlich Tumor; Chemokine CCL2; Chemokines, CXC; Inflammation; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Peritoneal Cavity; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Regional Blood Flow; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2007 |
The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; CD40 Ligand; Cell Line, Tumor; Endothelial Cells; Gene Expression Regulation, Enzymologic; Humans; Mice; Mice, SCID; Models, Biological; Neoplasms; Neovascularization, Pathologic; Platelet Activating Factor; Thrombin; Vascular Endothelial Growth Factor A | 2007 |
Interleukin-3 in vivo: kinetic of response of target cells.
Topics: Adult; Antigens, CD; Blood Cell Count; Bone Marrow; Dose-Response Relationship, Drug; Eosinophils; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Humans; Interleukin-3; Kinetics; Middle Aged; Monocytes; Neoplasms; Platelet Activating Factor; Recombinant Proteins | 1993 |
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
Topics: Aged; Animals; Blood Pressure; Disseminated Intravascular Coagulation; Female; Fibrinolysis; Guanidines; Humans; Male; Middle Aged; Neoplasms; Platelet Activating Factor; Platelet Count; Postoperative Complications; Rabbits; Serine Proteinase Inhibitors; Shock, Septic; Thiazoles; Thiazolidines | 1993 |
Clinical studies of IL-11, new platelet growth factor, presented.
Topics: Animals; Breast Neoplasms; Clinical Trials as Topic; Hematopoiesis; Humans; Interleukin-11; Neoplasms; Platelet Activating Factor; Recombinant Proteins; Sepsis; Thrombocytopenia | 1997 |
Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis.
Topics: Adult; Azepines; Calcium; Cell Membrane; Cytotoxicity, Immunologic; Gene Expression; Humans; Interferon-gamma; Killer Cells, Natural; Membrane Glycoproteins; Neoplasms; Perforin; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pore Forming Cytotoxic Proteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Transfection; Triazoles; Tumor Cells, Cultured | 2000 |
Platelet-mediated cytotoxicity and its enhancement by platelet activating factor.
Topics: Adenocarcinoma; Adult; Aged; Antibody-Dependent Cell Cytotoxicity; Blood Platelets; Humans; Middle Aged; Neoplasms; Platelet Activating Factor; Tumor Cells, Cultured | 1991 |
In vivo priming of human normal neutrophils by granulocyte-macrophage colony stimulating factor: effect on the production of platelet activating factor.
Topics: Acetyltransferases; Colony-Stimulating Factors; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Neoplasms; Neutrophils; Platelet Activating Factor; Recombinant Proteins; Time Factors | 1990 |
Decreased skin response to intradermal platelet-activating factor (PAF-acether) in cancer patients.
Topics: Adult; Female; Histamine; Humans; Male; Middle Aged; Neoplasms; Platelet Activating Factor; Skin | 1990 |
[Platelet aggregation after the reduction of nitro-blue tetrazolium by eosinophils].
Topics: Eosinophils; Humans; Hypersensitivity; Neoplasms; Nitroblue Tetrazolium; Oxidation-Reduction; Parasitic Diseases; Phagocytosis; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Tetrazolium Salts | 1985 |